Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Regimens in PPROM After 34 Weeks
NCT07148622Completed
- Sponsor
- Van Yuzuncu Yil University
- Start
- Oct 2024
- Primary completion
- Aug 2025
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, open-label trial of sulbactam, ampicillin, azithromycin, ceftriaxone, clarithromycin and 1 more in preterm premature rupture of membranes (pPROM) (2 arms), sponsored by Van Yuzuncu Yil University. Primary endpoints: Mode of birth checklist at 4 weeks, Neonatal birth weight at 4 weeks and 6 more. Started Oct 2024; status: completed.
02
Drugs
sulbactamampicillinazithromycinceftriaxoneclarithromycin
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT07148622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07148622.